Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial
Christian‐Hendrik Heeger(Asklepios Klinik Altona), Martin Bergmann(BG University Hospital Bergmannsheil Bochum), Dirk Haller(Leibniz-Institute for Food Systems Biology at the Technical University of Munich), Yanuar Zulkarnaen, Alessandro Cuneo(Maria Hilf Krankenhaus), Korff Krause(Asklepios Klinik St. Georg), Hölger Thiele(Leipzig Heart Institute), Kai Jaquet, Andreas Metzner(Asklepios Klinik St. Georg), Dietmar Kivelitz, Karl‐Heinz Kück(University Hospital Schleswig-Holstein), Carsten Schneider(Asklepios Klinik St. Georg), Tobias Schmidt(Asklepios Fachklinikum Brandenburg)
Cited by 21
Related Papers
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Critical review: vegetables and fruit in the prevention of chronic diseases
|European Journal of Nutrition|2012|1.8k